日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Tyrosine kinase inhibitor imatinib augments tumor immunity by depleting effector regulatory T cells

酪氨酸激酶抑制剂伊马替尼通过清除效应调节性T细胞来增强肿瘤免疫力。

Atsushi Tanaka # ,Hiroyoshi Nishikawa # ,Shinsuke Noguchi # ,Daisuke Sugiyama ,Hiromasa Morikawa ,Yoshiko Takeuchi ,Danbee Ha ,Naoya Shigeta ,Toshio Kitawaki ,Yuka Maeda ,Takuro Saito ,Yoshinori Shinohara ,Yoshihiro Kameoka ,Keiko Iwaisako ,Fumihiko Monma ,Kohshi Ohishi ,Julia Karbach ,Elke Jäger ,Kenichi Sawada ,Naoyuki Katayama ,Naoto Takahashi ,Shimon Sakaguchi

Differential control of human Treg and effector T cells in tumor immunity by Fc-engineered anti-CTLA-4 antibody

Fc 工程化抗 CTLA-4 抗体对肿瘤免疫中人类 Treg 和效应 T 细胞的差异控制

Danbee Ha, Atsushi Tanaka, Tatsuya Kibayashi, Atsushi Tanemura, Daisuke Sugiyama, James Badger Wing, Ee Lyn Lim, Karen Wei Weng Teng, Dennis Adeegbe, Evan W Newell, Ichiro Katayama, Hiroyoshi Nishikawa, Shimon Sakaguchi

Blocking glutamate carboxypeptidase II inhibits glutamate excitotoxicity and regulates immune responses in experimental autoimmune encephalomyelitis

阻断谷氨酸羧肽酶 II 可抑制谷氨酸兴奋毒性并调节实验性自身免疫性脑脊髓炎中的免疫反应

Danbee Ha, So Jin Bing, Ginnae Ahn, Jinhee Kim, Jinhee Cho, Areum Kim, Kalahe H I N M Herath, Hak Sun Yu, Sangmee Ahn Jo, Ik-Hyun Cho, Youngheun Jee